New shot eases shingles pain that Won't quit
NCT ID NCT07067892
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether a targeted ultrasound-guided nerve block (SPSIPB) can reduce pain in people with postherpetic neuralgia, a chronic pain condition that can linger after shingles. Researchers reviewed records of 34 adults who received this injection and measured pain levels, nerve pain features, and quality of life. The goal was to see if this procedure offers relief when standard treatments have failed.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
34 people
The number who actually took part.
- Started
-
Jul 2025
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients over 18 years of age who underwent a single-session ultrasound (US )guided serratus posterior superior intercostal plane block (SPSIPB) in the thoracic region (T1-T10 dermatomes) for PHN between June 2023 and February 2025 were evaluated. SPSIPB was performed in patients whose complaints persisted despite existing medical treatments.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients over 18 years of age \- who underwent a single-session ultrasound (US)-guided serratus posterior superior intercostal plane block (SPSIPB) in the thoracic region (T1-T10 dermatomes) for PHN between June 2023 and February 2025 were evaluated. -SPSIPB was performed in patients whose complaints persisted despite existing medical treatments. Exclusion Criteria:Patients were excluded if they had cervical disc herniation -a history of trauma or surgery involving the neck, shoulder, or back; -malignancy- kyphoscoliosis; a history of inflammatory diseases (e.g., rheumatoid arthritis, ankylosing spondylitis) * congenital anomalies of the spine; neck pain accompanied by neurological deficits * pregnancy * mental or psychotic disorders * hematologic diseases causing bleeding or coagulation disorders * use of antiplatelet or anticoagulant drugs or other medications predisposing to bleeding * severe systemic infections such as sepsis * local infection at the planned intervention site * known allergy to any of the drugs to be used; or a history of invasive procedures for PHN in the thoracic region within the past three months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Postherpetic neuralgia ( PHN ), ultrasound guided, block are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
İKanuni Sultan Süleyman Training and Research Hospital
Küçükçekmece, Istanbul, (507) 277-4773, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.